Skip to main content
. Author manuscript; available in PMC: 2016 Oct 3.
Published in final edited form as: Gynecol Oncol. 2011 Oct 19;124(1):148–152. doi: 10.1016/j.ygyno.2011.09.037

Fig. 3.

Fig. 3

Kaplan survival analysis revealed that for patients who received radiation+ chemotherapy or chemotherapy alone there is no significant independent value of SNCG in predicting DFS. The black curve is for SNCG− patients who received radiation + chemotherapy or chemotherapy alone, while the gray curve is for SNCG+ patients who received radiation + chemotherapy or chemotherapy alone. However, a difference in DFS probability rate was observed with 5 years DFS probability of 41.6% for the 27 SNCG+ patients and of 59.5% for the 53 SNCG− patients.